HRT Financial’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,869
Closed -$311K 3359
2025
Q1
$311K Sell
13,869
-50,072
-78% -$1.16M ﹤0.01% 1759
2024
Q4
$1.25M Buy
63,941
+19,593
+44% +$388K 0.01% 964
2024
Q3
$807K Buy
44,348
+19,804
+81% +$378K ﹤0.01% 1354
2024
Q2
$426K Buy
+24,544
New +$435K ﹤0.01% 1362
2023
Q3
Sell
-219,975
Closed -$5.74M 2945
2023
Q2
$5.74M Buy
+219,975
New +$5.81M 0.05% 251
2023
Q1
Sell
-50,132
Closed -$1.14M 3049
2022
Q4
$1.14M Buy
+50,132
New +$1.4M 0.02% 879
2022
Q1
Sell
-227,157
Closed -$5.88M 3702
2021
Q4
$5.88M Sell
227,157
-48,685
-18% -$1.21M 0.03% 242
2021
Q3
$6.5M Buy
+275,842
New +$9.63M 0.04% 249

Other funds holding PRVA

HRT Financial's PRVA Position: Q2 2025 in Review

HRT Financial sold out of Privia Health (PRVA) in Q2 2025, closing a stake of 13,869 shares — an estimated $311K sold.

HRT Financial first reported a position in PRVA in Q3 2021 and held it in 8 quarters. The position peaked at $6.5M in Q3 2021. 280 funds tracked by Wall St. Rank hold PRVA as of Q2 2025.

  • HRT Financial reported no remaining Privia Health position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 13,869 Privia Health shares in Q2 2025, an estimated $311K.
  • HRT Financial first reported a position in Privia Health in Q3 2021 and held it in 8 quarters.
  • HRT Financial's Privia Health position peaked at $6.5M in Q3 2021.
  • 280 funds tracked by Wall St. Rank held Privia Health as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.